Fatal tetanus in a drug abuser with 'protective' antitetanus antibodies

Journal of Emergency Medicine

Volumn 18, Issue 2, 2000, Pages 189-193

  Abrahamian, Fredrick M ^a   Pollack Jr , Charles V ^a   LoVecchio, Frank ^a   Nanda, Rohit ^a   Carlson, Richard W ^a  

^a Maricopa Integrated Health System   (United States)

Author keywords

Anoxic injury; Injecting drug user; Tetanus; Tetanus toxoid antibody

Indexed keywords

METRONIDAZOLE; NEUROMUSCULAR BLOCKING AGENT; PENICILLIN G; PENTOBARBITAL; PHENYTOIN; PROPOFOL; TETANUS ANTIBODY;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACKACHE; CASE REPORT; DRUG ABUSE; ELECTROENCEPHALOGRAM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HYPOXIA; MALE; MUSCLE SPASM; PRIORITY JOURNAL; RESPIRATORY FAILURE; SEIZURE; TETANUS;

ANTIBODIES, BACTERIAL; DISEASE PROGRESSION; FATAL OUTCOME; HUMANS; MALE; MIDDLE AGED; RESPIRATORY INSUFFICIENCY; SUBSTANCE ABUSE, INTRAVENOUS; TETANUS; TETANUS TOXOID;

EID: 0034142322     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-4679(99)00192-4     Document Type: Article

References (12)

1. Sneath P.A.T., Kerslake E.G., Scruby F. Tetanus immunity the resistance of guinea pigs to lethal spore doses induced by active and passive immunization . Am J Hyg. 25:1937;464-476.
2. Simonsen O., Bentzon M.W., Heron I. ELISA for the routine determination of antitoxic immunity to tetanus. J Biol Stand. 14:1986;231-239.
3. Crone N.E., Reder A.T. Severe tetanus in immunized patients with high anti-tetanus titers. Neurology. 42:1992;761-764.
4. Passen E.L., Andersen B.R. Clinical tetanus despite a "protective" level of toxin-neutralizing antibody. JAMA. 255:1986;1171-1173.
5. Pryor T., Onarecker C., Coniglione T. Elevated antitoxin titers in a man with generalized tetanus. J Fam Pract. 44:1997;299-303.
6. Berger S.A., Cherubin C.E., Nelson S., Levine L. Tetanus despite preexisting antitetanus antibody. JAMA. 240:1978;769-770.
7. Bleck T.P. Tetanus pathophysiology, management, and prophylaxis . Disease-a-Month. 37:1991;551-603.
8. CDC Surveillance Summaries. Tetanus surveillanceUnited States, 1995-1997. MMWR 1998;47:1-13.
9. Ipsen J. Changes in immunity and antitoxin level immediately after secondary stimulus with tetanus toxoid in rabbits. J Immunol. 86:1961;50-55.
10. Gergen P.J., McQuillan G.M., Kiely M., Ezzati-Rice T.M., Sutter R.W., Virella G. A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med. 332:1995;761-766.
11. Groleau G. Tetanus. Emerg Med Clin North Am. 10:1992;351-360.
12. Ahmadsyah I., Salim A. Treatment of tetanus an open study to compare the efficacy of procaine penicillin and metronidazole . BMJ. 291:1985;648-650.